Nephroprotective Measures in Critically Ill Patients With Moderate/Severe Acute Kidney Injury
ConditionAcute Kidney Injury
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversität Münster
About this trial
This study investigates to which extent recommended nephroprotective measures are implemented in critically ill patients with moderate or severe acute kidney injury.
Eligibility criteria
Qualifiers
Critically ill patients with moderate or severe AKI (KDIGO stage 2 / 3)
Requirement of vasopressors or mechanical ventilation
Age ≥ 18 years
Informed consent
Disqualifiers
Chronic kidney disease (CKD) with a glomerular filtration rate < 20ml/min
Chronic dialysis dependency
History of renal transplantation
Permanent ligation of the renal arteries
Trial design
Treatments tested in this trial
- Nephroprotective measures
Treatment groups
257 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov